First-in-human study of SBRT and adenosine pathway blockade to potentiate the benefit of immunochemotherapy in early-stage luminal B breast cancer: results of the safety run-in phase of the Neo-CheckRay trial.
Alex De CaluwéEmanuela RomanoPhilip PoortmansAndrea GombosElisa AgostinettoGuilherme Nader MartaZoe DenisStylianos DrisisChristophe VandekerkhoveAntoine DesmetCatherine PhilippsonLigia CraciunIsabelle VeysDenis LarsimontMarianne PaesmansDirk Van GestelRoberto SalgadoChristos SotiriouMartine Piccart-GebhartMichail IgnatiadisLaurence BuisseretPublished in: Journal for immunotherapy of cancer (2023)
NCT03875573.